Coronavirus: India Continues to See Low Daily Cases

The recovery rate stands at 96.51 percent while the fatality rate is 1.44 percent.

2 min read
Now the researchers have found that the first week and a half after hospital stay for COVID maybe especially dangerous.

With 15,968 new coronavirus infections reported in the last 24 hours, India continued its streak of low cases, with an overall tally mounting to 1,04,95,147, officials said on Wednesday.

On Tuesday, India recorded 12,584 new cases, the lowest single-day figure in over seven months. Before this, the lowest number was recorded on June 18 last year, when India reported 12,881 fresh Covid cases in a day.

The Ministry of Health and Family Welfare said 202 deaths were reported in the past 24 hours taking the death toll to 1,51,529. Since the last 19 days, less than 300 new deaths per day have been recorded in the country.

As per the Ministry data, till now, 1,01,29,111 people have recovered. Currently, there are 2,14,507 active cases. About 43.96 percent of patients with active infection are in healthcare facilities, while the rest are in home isolation.

The recovery rate stands at 96.51 percent while the fatality rate is 1.44 percent.

The total number of samples tested up to January 12 was 18,34,89,114 including 8,36,227 samples tested on Tuesday, the Indian Council of Medical Research said.

About 70 percent of the daily new cases are reported from seven states -- Kerala, Maharashtra, Chhattisgarh, Tamil Nadu, Gujarat, West Bengal, and Uttar Pradesh.

Meanwhile, the most-awaited mass vaccination drive is slated to begin from January 16, with the approval of two vaccines. The Central government plans to vaccinate nearly three crore people in the first phase of the drive.

The vaccine will be offered to one crore healthcare worker, along with two crore frontline and essential workers, 26 crore people above the age of 50, and one crore below 50 with comorbidities.

The Union Health Ministry has said that 1.1 crores 'Covishield' and 55 lakh 'Covaxin' doses have been procured at the cost of Rs 200 and Rs 206 per dose, respectively.

(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT)

(Subscribe to FIT on Telegram)

Stay Up On Your Health

Subscribe To Our Daily Newsletter Now.

Join over 120,000 subscribers!